News | Heart Failure | April 14, 2023

Air Pollution Linked with Elevated Risk of Fatal Heart Attacks and Strokes

Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023

Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023

Getty Images


April 14, 2023 — Deaths from cardiovascular disease are elevated on polluted days and for two days afterwards, according to research presented at ESC Preventive Cardiology 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in the International Journal of Environmental Research and Public Health.   

“Our study suggests that to preserve heart health it is advisable to plan time outdoors around air quality forecasts,” said study author Dr. Michal Swieczkowski of the Medical University of Bialystok, Poland. “When staying home is not an option, wearing a mask during peak pollution hours and avoiding areas with heavy traffic should be considered.” 

 This study examined the association between air pollution and death from cardiovascular disease overall, and from two types of cardiovascular disease, namely acute coronary syndromes and ischaemic stroke. The study was conducted in five cities in eastern Poland. Mortality data for 2016 to 2020 were obtained from the Central Statistical Office. Concentrations of particulate matter (PM)2.5, PM10, and nitrogen dioxide (NO2) were gathered from the Voivodeship Inspectorate for Environmental Protection. The main sources of these pollutants are road traffic and household heaters using coal or wood. 

A time-stratified case-crossover study design was used where for each participant, the researchers compared levels of each pollutant on the day of the week a death occurred (e.g. Wednesday) with pollutant levels on the same day of the week without any deaths (e.g. all remaining Wednesdays) within the same month. Using within-participant comparisons between days in the same month eliminated the potential confounding effects of participant characteristics and time trends. Similar analyses were conducted for pollution levels one day and two days before a death occurred. 

During the five-year study, there were a total of 87,990 deaths, of which 34,907, 9,688, and 3,776 were due to cardiovascular disease, acute coronary syndromes and ischaemic stroke, respectively. Regarding death from cardiovascular disease overall, a 10 μg/m3 rise in PM2.5, PM10 and NO2 was associated with a 3%, 3% and 8% increased risk, respectively, of dying on the same day. The risks of dying from cardiovascular disease were similar one and two days after the polluted day. 

Regarding death from acute coronary syndromes, a 10 μg/m3 rise in PM2.5 and PM10 was associated with a 3% and 2% increased risk, respectively, of dying on the same day. Meanwhile, a 10 μg/m3 rise in PM2.5, PM10 and NO2 was associated with a 3%, 3% and 4% increased risk, respectively, of dying from an acute coronary syndrome the following day. For ischaemic stroke, a 10 μg/m3 rise in PM2.5 was associated with a 3% increased risk of death the following day. 

Dr. Swieczkowski said: “The results show worrying associations between air pollution and death from cardiovascular disease. Policymakers should consider measures to promote clean air including subsidies for upgrading household heating systems and vehicle-free zones.” 

For more information: www.escardio.org 


Find more European Society of Cardiology Coverage here 


Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now